This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirsaliotis, A.
Right arrow Articles by Brighty, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirsaliotis, A.
Right arrow Articles by Brighty, D. W.

 Previous Article  |  Next Article 

Journal of Virology, May 2008, p. 4965-4973, Vol. 82, No. 10
0022-538X/08/$08.00+0     doi:10.1128/JVI.02458-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Nonhelical Leash and {alpha}-Helical Structures Determine the Potency of a Peptide Antagonist of Human T-Cell Leukemia Virus Entry{triangledown}

Antonis Mirsaliotis, Daniel Lamb, and David W. Brighty*

Biomedical Research Centre, Ninewells Hospital and Medical School, The University, Dundee DD1 9SY, Scotland, United Kingdom

Received 15 November 2007/ Accepted 20 February 2008

Viral fusion proteins mediate the entry of enveloped viral particles into cells by inducing fusion of the viral and target cell membranes. Activated fusion proteins undergo a cascade of conformational transitions and ultimately resolve into a compact trimer of hairpins or six-helix bundle structure, which pulls the interacting membranes together to promote lipid mixing. Significantly, synthetic peptides based on a C-terminal region of the trimer of hairpins are potent inhibitors of membrane fusion and viral entry, and such peptides are typically extensively {alpha}-helical. In contrast, an atypical peptide inhibitor of human T-cell leukemia virus (HTLV) includes {alpha}-helical and nonhelical leash segments. We demonstrate that both the C helix and C-terminal leash are critical to the inhibitory activities of these peptides. Amino acid side chains in the leash and C helix extend into deep hydrophobic pockets at the membrane-proximal end of the HTLV type 1 (HTLV-1) coiled coil, and these contacts are necessary for potent antagonism of membrane fusion. In addition, a single amino acid substitution within the inhibitory peptide improves peptide interaction with the core coiled coil and yields a peptide with enhanced potency. We suggest that the deep pockets on the coiled coil are ideal targets for small-molecule inhibitors of HTLV-1 entry into cells. Moreover, the extended nature of the HTLV-1-inhibitory peptide suggests that such peptides may be intrinsically amenable to modifications designed to improve inhibitory activity. Finally, we propose that leash-like mimetic peptides may be of value as entry inhibitors for other clinically important viral infections.


* Corresponding author. Mailing address: The Biomedical Research Centre, Ninewells, Hospital and Medical School, The University, Dundee DD1 9SY, Scotland, United Kingdom. Phone: 44 1382 660111. Fax: 44 1382 669993. E-mail: d.w.brighty{at}dundee.ac.uk

{triangledown} Published ahead of print on 27 February 2008.


Journal of Virology, May 2008, p. 4965-4973, Vol. 82, No. 10
0022-538X/08/$08.00+0     doi:10.1128/JVI.02458-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Markosyan, R. M., Leung, M. Y., Cohen, F. S. (2009). The Six-Helix Bundle of Human Immunodeficiency Virus Env Controls Pore Formation and Enlargement and Is Initiated at Residues Proximal to the Hairpin Turn. J. Virol. 83: 10048-10057 [Abstract] [Full Text]  
  • Lamb, D., Mirsaliotis, A., Kelly, S. M., Brighty, D. W. (2009). Basic Residues Are Critical to the Activity of Peptide Inhibitors of Human T Cell Leukemia Virus Type 1 Entry. J. Biol. Chem. 284: 6575-6584 [Abstract] [Full Text]